1-6 of 6
Authors: D. De Ridder
Journal Article
PS-3-5 Dendritic Cells and Cytotoxic T-Lymphocytes Driving the Inflammation in the Peyronie's Disease Micro-Environment Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_2, June 2020, Pages S129–S130, https://doi.org/10.1016/j.jsxm.2020.04.037
Published: 01 June 2020
Journal Article
PS-04-004 Transcriptome-wide Analysis of Peyronie's Disease Plaques using RNA Sequencing Uncovers Targetable Signaling Pathways for Medical Therapy Get access
The Journal of Sexual Medicine, Volume 16, Issue Supplement_2, May 2019, Pages S11–S12, https://doi.org/10.1016/j.jsxm.2019.03.064
Published: 01 May 2019
Journal Article
HP-01-001 Simvastatin and the Rho-kinase Inhibitor Y-27632 Prevent Myofibroblast Transformation in Peyronie’s Disease-derived Fibroblasts via Inhibition of YAP/TAZ Nuclear Translocation. Get access
The Journal of Sexual Medicine, Volume 16, Issue Supplement_2, May 2019, Page S30, https://doi.org/10.1016/j.jsxm.2019.03.116
Published: 01 May 2019
Journal Article
019 Galanin Mediates Endogenous Nitrinergic Nerve Outgrowth in Vitro and Partially Restores Erectile Function after Cavernous Nerve Injury in Vivo Get access
The Journal of Sexual Medicine, Volume 15, Issue Supplement_3, July 2018, Page S131, https://doi.org/10.1016/j.jsxm.2018.04.023
Published: 01 July 2018
Journal Article
017 Anti-Fibrotic Properties of RhoA Kinase-Inhibition in a Cell Culture Model of Peyronie’s Disease Get access
The Journal of Sexual Medicine, Volume 15, Issue Supplement_3, July 2018, Page S130, https://doi.org/10.1016/j.jsxm.2018.04.021
Published: 01 July 2018
Journal Article
277 Interplay Between TNFa and TGF-B1 in a Cell Culture Model of Peyronie’s Disease Get access
The Journal of Sexual Medicine, Volume 15, Issue Supplement_3, July 2018, Page S234, https://doi.org/10.1016/j.jsxm.2018.04.242
Published: 01 July 2018
